Ben Ward - Author for 24/7 Wall St.
Lastest Stories by Ben Ward
Management of at-home fixed wireless telco provider Starry withdrew guidance and announced stark cost-cutting measures while providing a third-quarter update to investors.
Published:
Shares of biopharma Talaris Therapeutics tumbled after management reported a fatality of a patient that was undergoing a phase 1 trial.
Published:
Shares of small-cap casino and resort Monarch rallied after the company released third-quarter results that came in well above expectations.
Published:
Shares of emerging electric vehicle producer Mullen Automotive skyrocketed after management announced that it had acquired bankruptcy assets from Electric Last Mile Solutions.
Published:
Shares of America's leading motorhome manufacturer tumbled after what seemed like an earnings beat at a first glance.
Published:
Residential home and apartment rental company Tricon Residential has announced that it completed the sale of a 20% equity interest in a portfolio of 23 Sun Belt apartment buildings.
Published:
Jefferies analysts switch Staples sector to underweight and REITs to overweight with these 9 key pic
Analysts at Jefferies investment banks have had a shift in strategy as they changed sector preferences amidst global equity market volatility and uncertainty.
Published:
Enviva insiders purchased shares as the stock fell significantly due to a short seller attack.
Published:
Donald Trump’s social media company app, Truth Social had been approved to be added to the Google Play Store.
Published:
Citi Trends Chief Executive Officer David Makuen recently bought 4,000 shares of company stock worth about $75,000.
Published:
Shares of El Pollo Loco received a nice boost after management announced that they had declared a one-off special dividend and a new share buyback program.
Published:
Exela Technologies shares fell on Tuesday, reversing Monday's jump.
Published:
Dice Therapeutics Experiences Stellar 62% Gain on Phase 1 Trial Data And Launches $250 Million Offer
Dice Therapeutics shares jumped after the company released initial Phase 1 trial results for its psoriasis treatment.
Published:
Here is a look at some portfolio changes at hedge fund Two Sigma.
Published:
Cannabis stocks rallied after U.S. President Joe Biden pardoned all people formerly convicted of federal marijuana possession.
Published: